FDA greenlights targeted therapy for lung cancer mutation
https://healthell.blogspot.com/2021/06/fda-greenlights-targeted-therapy-for.html
FDA greenlights targeted therapy for lung cancer mutation
The Food and Drug Administration has approved the first drug for a specific mutation causing lung cancer in adult patients who have undergone at least one systemic treatment, such as chemotherapy.
